1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NATCO PHARMA LTD.

Natco Pharma Ltd. NSE: NATCOPHARM | BSE: 524816

Natco Pharma Ltd. Live Share Price Today, Share Analysis and Chart

Value Stock, Under Radar
Download real time

827.60 1.00 (0.12%)

49.51% Fall from 52W High

333.6K NSE+BSE Volume

NSE 17 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
70.0 / 100
Valuation Score
Affordable Valuation
64.5 / 100
Momentum Score
Technically Bearish
32.7 / 100
Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM
Analyst Price Target
1,099
1Yr Price target upside is 33%
12 analysts

25

S

8

W

1

O

2

T

SWOT Analysis

Natco Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

19 Feb, 2025 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings C…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings C…
pdf link AI Summary
13 Feb, 2025 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / …
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / …
pdf link
13 Feb, 2025 TRENDLYNE
Natco Pharma Results Earnings Call for Q3FY25
Natco Pharma Results Earnings Call for Q3FY25
video link
21 Nov, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / …
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / …
pdf link
13 Nov, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / …
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / …
pdf link
13 Nov, 2024 TRENDLYNE
Natco Pharma Results Earnings Call for Q2FY25
Natco Pharma Results Earnings Call for Q2FY25
video link
21 Aug, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings C…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings C…
pdf link AI Summary
13 Aug, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings C…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings C…
pdf link
13 Aug, 2024 TRENDLYNE
Natco Pharma Results Earnings Call for Q1FY25
Natco Pharma Results Earnings Call for Q1FY25
video link
04 Jun, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings C…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings C…
pdf link AI Summary
29 May, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / …
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / …
pdf link
28 May, 2024 TRENDLYNE
Natco Pharma Results Earnings Call for Q4FY24
Natco Pharma Results Earnings Call for Q4FY24
audio video link
All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
30 Apr, 2024 ICRA RATINGS
Natco Pharma Limited
Ratings reaffirmed
link
28 Apr, 2023 ICRA RATINGS
Natco Pharma Limited
Natco Pharma Limited: Ratings reaffirmed
link
28 Apr, 2022 ICRA RATINGS
Natco Pharma Limited
Natco Pharma Limited: Ratings reaffirmed
link
29 Apr, 2021 ICRA RATINGS
Natco Pharma Limited
Natco Pharma Limited: Ratings reaffirmed
link
23 Mar, 2020 ICRA RATINGS
Natco Pharma Limited
Natco Pharma Limited: Ratings reaffirmed; rated amount enhanced
link
04 Apr, 2019 ICRA RATINGS
Natco Pharma Limited
Natco Pharma Limited: Ratings reaffirmed; rated amount enhanced
link
05 Apr, 2018 ICRA RATINGS
Natco Pharma Limited
Natco Pharma Limited: Ratings of [ICRA]AA(Stable)/[ICRA]A1+ reaffirmed, rated amount enhanced
link
10 Jul, 2017 ICRA RATINGS
Natco Pharma Limited
ICRA assigns rating of [ICRA]A1+ to enhanced commercial paper programme of Natco Pharma Limited
link
20 Feb, 2017 ICRA RATINGS
Natco Pharma Limited
CRA upgrades ratings for bank loans of Natco Pharma Limited to [ICRA]AA (Stable) and reaffirmed short term rating [ICRA]A1+, rated …
link
12 Feb, 2025 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
12 Nov, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
12 Aug, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
29 May, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
28 May, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
15 Feb, 2024 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
15 Nov, 2023 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
10 Aug, 2023 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
30 May, 2023 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
09 Feb, 2023 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
11 Nov, 2022 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
10 Aug, 2022 BSE INDIA
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link

Natco Pharma Ltd. FAQ

How is Natco Pharma Ltd. today?
Natco Pharma Ltd. today is trading in the green, and is up by 0.12% at 827.60.
Natco Pharma Ltd. is currently trading up 0.12% on an intraday basis. In the past week the stock rose 10.86%. stock has been down -33.23% in the past quarter and fell -16.14% in the past year. You can view this in the overview section.